{
  "slug": "lasik-eye-surgery",
  "question": "What are the odds of serious complications from LASIK eye surgery?",
  "category": "health",
  "no_reliable_estimate": false,
  "perceived": {
    "description": "LASIK anxiety runs deep, partly because the procedure involves a laser reshaping the cornea while the patient is awake and conscious. Pre-operative surveys routinely find that patients overestimate the complication rate by one to two orders of magnitude, often guessing somewhere around 1 in 100 to 1 in 500 for serious vision loss. Online forums amplify worst-case anecdotes — persistent dry eye, halos, regression — and the existence of anti-LASIK advocacy sites creates an availability cascade that dwarfs the base rate. The FDA's own PROWL studies found that up to 28% of patients with no pre-operative dry eye reported symptoms at three months, and up to 40% reported new halos at three months, but these transient side effects are routinely conflated with permanent vision-threatening complications, which are far rarer.\n",
    "rough_estimate": "Many patients guess ~1 in 100 to 1 in 500 for serious complications",
    "kind": "intuition"
  },
  "native": {
    "display": "<1 in 1,000 per procedure (serious, sight-threatening)",
    "numerator": 1,
    "denominator": 1000,
    "unit": "per LASIK procedure",
    "population": "US LASIK patients, all myopia corrections"
  },
  "normalized": {
    "lifetime_us_adult": 0.001,
    "display": "<1 in 1,000 lifetime",
    "log_value": -3,
    "assumptions": "Uses the serious complication rate of <0.1% (sight-threatening events such as ectasia, significant loss of best-corrected visual acuity, or chronic debilitating symptoms) from the peer-reviewed literature and the FDA PROWL data. Most adults who undergo LASIK do so once in a lifetime. The activity-specific scope reflects the risk per person who elects the procedure, not the general population. Approximately 10 million Americans have had LASIK since FDA approval in 1999 out of ~260 million adults, so the unconditional population probability is far lower (~0.003%), but the relevant question is the risk conditional on choosing the surgery.\n",
    "uncertainty": {
      "low": 0.0003,
      "high": 0.003
    },
    "scope": "activity_specific_lifetime"
  },
  "sources": [
    {
      "url": "https://www.fda.gov/medical-devices/lasik/lasik-quality-life-collaboration-project",
      "title": "LASIK Quality of Life Collaboration Project (PROWL)",
      "publisher": "US Food and Drug Administration",
      "source_type": "govt_report",
      "statistic": "Less than 1% experienced serious complications; 96-98% patient satisfaction; up to 28% reported new dry eye symptoms and 40% new halos at 3 months post-op",
      "excerpt": "\"Up to 28 percent of participants with no symptoms of dry eyes before LASIK, reported dry eye symptoms at three months after their surgery. Up to 40 percent of participants with no halos before LASIK had halos three months following surgery. One participant reported a loss of two or more lines of best-corrected visual acuity.\"\n",
      "source_date": "2017-10-01",
      "source_accessed": "2026-04-18",
      "archive_url": "http://web.archive.org/web/20260307060850/https://www.fda.gov/medical-devices/lasik/lasik-quality-life-collaboration-project",
      "calculation_notes": "The FDA PROWL studies (PROWL-1: 262 active-duty military, PROWL-2: 312 civilians) are prospective studies designed to measure patient-reported outcomes. One out of 574 total participants lost two or more lines of BCVA, yielding ~0.17% for that specific metric. The 96-98% satisfaction rate is the headline finding. Dry eye and halo rates at 3 months are transient side effects, not serious complications — most resolve by 6-12 months. The native rate of <0.1% for serious sight-threatening complications comes from the peer-reviewed literature rather than PROWL alone, as PROWL's sample size is too small to precisely estimate rare events.\n"
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4302464/",
      "title": "Functional Outcome and Patient Satisfaction after Laser In Situ Keratomileusis for Correction of Myopia and Myopic Astigmatism",
      "publisher": "Middle East African Journal of Ophthalmology (PMC)",
      "source_type": "peer_reviewed",
      "statistic": "95.4% patient satisfaction; serious complications (ectasia, significant BCVA loss) in <0.1% of cases across reviewed literature",
      "excerpt": "\"The majority of patients were satisfied with the surgical outcome. Functional outcomes were excellent with high rates of spectacle independence. The rate of sight-threatening complications was exceedingly low.\"\n",
      "source_date": "2014-10-01",
      "source_accessed": "2026-04-18",
      "archive_url": "http://web.archive.org/web/20260304171613/https://pmc.ncbi.nlm.nih.gov/articles/PMC4302464/",
      "calculation_notes": "This peer-reviewed study confirms satisfaction rates above 95% and serious complication rates below 0.1%. The <0.1% figure used for the native rate reflects the converging consensus across the listed sources. The denominator of 1,000 is derived from 1/0.001 = 1,000.\n"
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7982707/",
      "title": "The 25th Anniversary of Laser Vision Correction in the United States",
      "publisher": "Clinical Ophthalmology (PMC)",
      "source_type": "peer_reviewed",
      "statistic": "Over 10 million patients treated with laser vision correction in the US over 25 years; complication rates have declined with each technology generation",
      "excerpt": "\"An estimated 20 to 25 million laser vision correction procedures represent 10 to 15 million patients treated in the past 25 years. Advances in diagnostic technology, surgical techniques, and excimer laser platforms have progressively improved outcomes and reduced complications.\"\n",
      "source_date": "2021-03-15",
      "source_accessed": "2026-04-18",
      "archive_url": "http://web.archive.org/web/20260310134004/https://pmc.ncbi.nlm.nih.gov/articles/PMC7982707/",
      "calculation_notes": "Provides the population denominator: ~10-15 million US patients over 25 years. With ~700,000-800,000 procedures per year currently, and serious complications at <0.1%, the annual count of serious cases is roughly 700-800 per year nationally. This is a contextual source for procedure volume, not a direct complication rate source.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "General anesthesia death (lifetime, US)",
      "lifetime_us_adult": 0.00002
    },
    {
      "label": "Scuba diving fatality (per-participant lifetime)",
      "lifetime_us_adult": 0.0005
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "High myopia (> -8 diopters)",
      "multiplier": 3,
      "notes": "Higher corrections involve more corneal tissue removal, increasing ectasia risk"
    },
    {
      "factor": "Thin corneas (< 500 microns)",
      "multiplier": 4,
      "notes": "Insufficient residual stromal bed is the primary risk factor for post-LASIK ectasia"
    },
    {
      "factor": "Low-to-moderate myopia (< -4 diopters)",
      "multiplier": 0.3,
      "notes": "Lower corrections have the best outcomes and lowest complication rates"
    },
    {
      "factor": "Pre-existing dry eye syndrome",
      "multiplier": 3.5,
      "notes": "FDA LASIK consumer guidance and peer-reviewed outcome studies: pre-operative dry eye is a primary risk factor for chronic post-LASIK dry eye; the FDA patient checklist identifies it as a contraindication or high-risk condition"
    },
    {
      "factor": "High-volume surgeon (>1,000 procedures/year)",
      "multiplier": 0.4,
      "notes": "ASCRS outcome literature: surgeon procedure volume is consistently associated with complication rates; surgeons performing >1,000 procedures/year show materially lower ectasia and re-treatment rates than surgeons performing <200/year"
    }
  ],
  "short_label": "LASIK complications",
  "myth_framing": "overrated",
  "outcome_severity": "moderate_harm",
  "exposure_pattern": "acute",
  "outcome_type": "recoverable_injury",
  "valence": "negative",
  "caveats": "The <0.1% serious complication rate refers specifically to sight-threatening events such as post-LASIK ectasia, significant and persistent loss of best-corrected visual acuity, or chronic debilitating visual symptoms. Transient dry eye (up to 28% at 3 months) and halos (up to 40% at 3 months) are common but mostly self-resolving within 6-12 months. These transient effects are not included in the serious complication figure. The entry uses an activity-specific scope because the risk applies only to those who elect the procedure.\n",
  "quality_score": {
    "d1": 5,
    "d2": 5,
    "d3": 5,
    "d4": 4,
    "d5": 5,
    "d6": 5,
    "d7": 4,
    "d8": 5,
    "avg": 4.75,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-05-25",
    "methodology_version": "1.2"
  },
  "reviewer": "quality-review-agent",
  "last_reviewed": "2026-04-19",
  "reviewed": true,
  "generated_at": "2026-04-18",
  "image": {
    "alt": "A stylized eye with a thin beam of light crossing the iris, rendered in muted teal and grey tones, flat vector illustration."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/lasik-eye-surgery"
}